News - Press Releases, Company Statements, Media Stories - Biocon
Access our News section - Press Releases, Company Statements, Media Stories, Factsheet, Leadership Profile, Reports, Video & Image Gallery
Press Releases - Biocon - Global Biopharmaceutical company
3 days ago · Access Biocon's latest & archived press releases, intended information for business journalists, News & Social Media, Analysts & Investors...
News - Posts - Biocon
Dec 24, 2024 · Biocon Biologics Recognized as Asia IP Elite for 2024 by IAM, Cementing Leadership in Intellectual Property Excellence
Media Stories - Biocon - Global Biopharmaceutical company
Access Biocon's latest & archived Media Stories published by various publishers across the world in offline & digital spectrum
Biocon Biologics Completes Acquisition of Viatris’ Global …
Nov 29, 2022 · Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), announced today that it has successfully completed its multi-billion-dollar (USD) acquisition of the global biosimilars business of its partner Viatris Inc. (NASDAQ: VTRS).
Biocon Limited signs an exclusive licensing and supply agreement …
Apr 17, 2024 · Biocon Limited (BSE code: 532523, NSE: BIOCON), an innovation-led global biopharmaceutical company, today announced the signing of an exclusive licensing and supply agreement with Biomm S.A., a specialty pharmaceutical company in Brazil, for the commercialization of its vertically integrated drug product, Semaglutide (gOzempic), which is used ...
Biocon - India's largest biopharmaceutical company
3 days ago · Biocon is an innovation led fully integrated biopharmaceutical company that develop affordable biosimilars, generic formulations & complex APIs
Biocon Biologics to Acquire Viatris’ Biosimilars Assets for up to …
Feb 27, 2022 · Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), announced today that it has entered into a definitive agreement with its partner Viatris Inc. (NASDAQ: VTRS). Accordingly, Biocon Biologics Ltd. (BBL) will acquire Viatris’ biosimilars business to create a unique fully integrated global biosimilars enterprise.
News - Posts - Page 14 of 32 - Biocon
Nov 4, 2021 · Biocon Biologics and Viatris Announce Insulin Glargine (insulin glargine-yfgn) Injection Will Be Offered Through the Walgreens Prescription Savings Club
Biocon Campus - Biocon
Biocon Biologics: New state-of-the-art biologics drug substance facility for monoclonal antibodies, Biocon Park, Bengaluru India.